University of Michigan – Ann Arbor, 1990, M.D.
University of Michigan – Ann Arbor, 1987, B.S.
Molecular and cell biology of gastrointestinal cancer
Genetic and epigenetic alterations in cancer
Hereditary cancer syndromes
Clinical management of gastrointestinal cancer family syndromes
Colon cancer prevention
ColoCare cohort study: Prospective cohort study of people with colorectal cancer. The goal of the study is to identify factors (lifestyle, molecular features of the cancer, etc) that affect prognosis.
GLNE010: A validation and comparison of biomarkers for the early detection of colorectal adenocarcinoma. Using a population of 6000 participants at 10-20 sites across the US and Canada, this study will validate stool, serum and urine biomarkers for colorectal cancer. The biomarker test results are compared to clinical screening or surveillance colonoscopy to see if they can detect adenomas >1cm, high grade dysplasia and adenocarcinoma.
Detection of rare mutant alleles in plasma: Development of novel molecular methods to develop a blood test to identify malignant pancreatic tumors
Laboratory based studies:
Identify and Validate Novel Epigenetic Molecular Markers for Colorectal Neoplasm
Genetic Determinants of Barrett’s Esophagus and Esophageal Adenocarcinoma
Novel Biomarkers for the Prevention and Treatment of Colon Cancer
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.